Department of Cancer Research and Molecular Medicine
Department of Cancer Research and Molecular Medicine aims at carrying out high quality research, supervision and teaching for better health. The department has a central role in teaching and supervision of medical students, as well as master- and ph.d-students in molecular medicine. The activities comprise basic- and clinical research within oncology and mechanisms of cancer development, palliative medicine, haematology, dermatology & venerology, infectious disease, molecular cell biology, physiology, immunology, toxicology, gastroenterology and gastrosurgery, experimental surgery, endocrinology, nephrology, urology and medical ethics.
Photodynamic Therapy Group acknowledged by the Norwegian Medical Association
(24.05.2012) The Norwegian Photodynamic Therapy Group has received the Norwegian Medical Association's Quality Prize for Specialist Health Service for its recommendations on the use of local photodynamic therapy in the treatment of non-melanoma skin cancer.
Photodynamic Therapy Group acknowledged by the Norwegian Medical Association
(24.05.2012) The Norwegian Photodynamic Therapy Group has received the Norwegian Medical Association's Quality Prize for Specialist Health Service for its recommendations on the use of local photodynamic therapy in the treatment of non-melanoma skin cancer.
Non-melanoma skin cancer is the most common cancer in Norway, and the number of cases is still increasing. Norway has pioneered the development of local photodynamic therapy, which has been an approved treatment form for non-melanoma skin cancer in the country since 2003.
Local photodynamic therapy is a multi-step treatment, which includes several practical procedures. The procedures have been practiced differently, and some appear not to achieve adequate effect. It was therefore necessary to go through and systematize routines to optimize treatment.
The research, which was carried out in the period 2007-2010, has resulted in practical recommendations, and helps give patients good and relevant information ahead of treatment. Special emphasis has been given to specific measures to reduce pain during treatment.
Consultant Eide Christensen received the prize on behalf of the group at the Medical Association's board meeting this week.
The group's work is presented in the article "Guidelines for Practical Use of MAL-PDT in Non-Melanoma Skin Cancer". Christensen is Lead Author and Professor Cato Mørk is Senior Author. Both belong to the Department of Cancer Research and Molecular Medicine, NTNU.
Contributing authors are: Trond Warloe, Susanne Kroon, Jüren Funk, Per Helsing, Ana M Soler, Henning Stang, and Øystein Vatne. The article has been published in the Journal of the European Academy of Dermatology and Venereology.
The group's recommendations have been presented at meetings and congresses, and have been recognized internationally.
Thu, 24 May 2012 15:19:39 +0200
Contact IKM
Phone:
+47 72 82 52 63
Fax:
+47 72 57 14 63
E-mail:
ikm-post@medisin.ntnu.no
Visiting address:
3rd floor Gastrosenteret
Prinsesse Kristinsgt. 1
Trondheim
Postal address:
Det medisinske fakultet
Institutt for Kreftforskning og molekylær medisin
Postboks 8905
N-7491 Trondheim
Norway
